Related Experiment Video
Updated: Jul 15, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Cardiovascular manifestations in Fabry disease: a clinical and echocardiographic study
1Westmead Hospital, Westmead, NSW 2145, Australia. normansadick@swiftdsl.com.au
Insights
Fabry disease commonly causes left ventricular hypertrophy (LVH) and extracardiac issues. Echocardiography reveals increased LV mass and altered diastolic function, suggesting Fabry disease in unexplained cardiac cases.
Area of Science:
- Cardiology
- Genetics
- Rare Diseases
Background:
- Fabry disease is a rare genetic disorder affecting multiple organs.
- Cardiovascular involvement is a significant complication, often leading to left ventricular hypertrophy (LVH).
- Early diagnosis and management are crucial for improving patient outcomes.
Purpose of the Study:
- To review clinical and echocardiographic findings in Fabry patients.
- To compare echocardiographic parameters between Fabry patients and healthy controls.
- To assess the utility of echocardiography in diagnosing Fabry disease-related cardiac manifestations.
Main Methods:
- Retrospective review of clinical data and echocardiograms from 12 Fabry patients.
- Comparison of echocardiographic findings with a control group.
- Analysis of myocardial biopsy results in a subset of patients.
Main Results:
- Nine out of 12 patients exhibited left ventricular hypertrophy (LVH).
- Echocardiography showed significantly increased LV mass and prolonged isovolumetric relaxation time (IVRT) in Fabry patients.
- Reduced septal E' velocity by Doppler tissue imaging (DTI) was observed in the Fabry group.
Conclusions:
- Fabry disease should be considered in patients with unexplained LVH and hypertrophic cardiomyopathy.
- Echocardiography is valuable for detecting cardiac abnormalities in Fabry disease.
- Extracardiac manifestations are prevalent and should prompt cardiac evaluation.
Abstract:
This study reviews the clinical and echocardiographic findings in a cohort of Fabry patients (n=12) and compares echocardiographic findings to normal controls. Almost all patients had extracardiac manifestations. Five out of 12 patients had cardiovascular symptoms. Nine out of 12 patients had left ventricular hypertrophy (LVH) on the electrocardiogram (ECG) and one patient had short PR interval. Three patients had epicardial coronary disease. Four patients had 'rat-tail' appearance on left ventriculogram. Six patients who had myocardial biopsy showed extensive vacuolation of the myocytes on light microscopy and concentric, myelinoid lamellar cytoplasmic inclusion bodies on electron microscopy. On echocardiography, LV mass was significantly increased in the Fabry group compared to normal controls. Traditional parameters of diastolic function including peak E velocity, peak A velocity and deceleration time were no different to normal controls. The IVRT was significantly prolonged in the Fabry subjects. The PV atrial reversal duration exceeded that of mitral A wave duration in the Fabry group. The septal E' velocity with Doppler tissue imaging (DTI) was significantly lower in the Fabry group than the normal controls. Fabry disease should be considered in the differential diagnosis in patients with unexplained LVH and late onset hypertrophic cardiomyopathy. Extracardiac manifestations are common.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Cardiomyopathy II: Dilated Cardiomyopathy
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...